The present invention relates to a composition useful for the treatment of lipid metabolism disorders, comprising one or more of the following active ingredients: (a) extract of rice fermented with Monascus purpureus, (b) at least one omega-3 fatty acid, (c) L-carnitine or a salt thereof； and one or more of the following active ingredients: (d) at least one policosanol or a natural extract containing policosanols； (e) resveratrol or a natural extract containing resveratrol； (f) Coenzyme Q10； and (g) at least one vitamin.
